These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19155081)

  • 21. A new scoring system for prognostic stratification of patients with alcoholic hepatitis.
    Dominguez M; Rincón D; Abraldes JG; Miquel R; Colmenero J; Bellot P; García-Pagán JC; Fernández R; Moreno M; Bañares R; Arroyo V; Caballería J; Ginès P; Bataller R
    Am J Gastroenterol; 2008 Nov; 103(11):2747-56. PubMed ID: 18721242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of alcoholic hepatitis: a prospective comparison of scoring systems.
    Lafferty H; Stanley AJ; Forrest EH
    Aliment Pharmacol Ther; 2013 Sep; 38(6):603-10. PubMed ID: 23879668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
    Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Garcia-Saenz-de-Sicilia M; Duvoor C; Altamirano J; Chavez-Araujo R; Prado V; de Lourdes Candolo-Martinelli A; Holanda-Almeida P; Becerra-Martins-de-Oliveira B; Fernandez-de-Almeida S; Bataller R; Caballeria J; Duarte-Rojo A
    Am J Gastroenterol; 2017 Feb; 112(2):306-315. PubMed ID: 27922027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
    Nguyen-Khac E; Thevenot T; Piquet MA; Benferhat S; Goria O; Chatelain D; Tramier B; Dewaele F; Ghrib S; Rudler M; Carbonell N; Tossou H; Bental A; Bernard-Chabert B; Dupas JL;
    N Engl J Med; 2011 Nov; 365(19):1781-9. PubMed ID: 22070475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.
    Tilg H; Jalan R; Kaser A; Davies NA; Offner FA; Hodges SJ; Ludwiczek O; Shawcross D; Zoller H; Alisa A; Mookerjee RP; Graziadei I; Datz C; Trauner M; Schuppan D; Obrist P; Vogel W; Williams R
    J Hepatol; 2003 Apr; 38(4):419-25. PubMed ID: 12663232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica.
    Karppinen J; Korhonen T; Malmivaara A; Paimela L; Kyllönen E; Lindgren KA; Rantanen P; Tervonen O; Niinimäki J; Seitsalo S; Hurri H
    Spine (Phila Pa 1976); 2003 Apr; 28(8):750-3; discussion 753-4. PubMed ID: 12698115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcoholic hepatitis: Prognosis and treatment.
    Casanova J; Bataller R
    Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
    Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
    Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline in severe alcoholic hepatitis: a prospective, randomised trial.
    Sidhu SS; Goyal O; Singla M; Bhatia KL; Chhina RS; Sood A
    J Assoc Physicians India; 2012 May; 60():20-2. PubMed ID: 23029716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of prednisolone in patients with severe alcoholic hepatitis.
    Ramond MJ; Poynard T; Rueff B; Mathurin P; Théodore C; Chaput JC; Benhamou JP
    N Engl J Med; 1992 Feb; 326(8):507-12. PubMed ID: 1531090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic inflammatory response syndrome in patients with liver cirrhosis.
    Abdel-Khalek EE; El-Fakhry A; Helaly M; Hamed M; Elbaz O
    Arab J Gastroenterol; 2011 Dec; 12(4):173-7. PubMed ID: 22305496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model of disease severity in alcoholic hepatitis and novel prognostic insights.
    Enciu VT; Ologeanu PM; Călin-Necula AM; Moldoveanu AC; Oprea-Călin G; Fierbinţeanu-Braticevici C
    Rom J Intern Med; 2024 Jun; 62(2):194-202. PubMed ID: 38180800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
    Louvet A; Naveau S; Abdelnour M; Ramond MJ; Diaz E; Fartoux L; Dharancy S; Texier F; Hollebecque A; Serfaty L; Boleslawski E; Deltenre P; Canva V; Pruvot FR; Mathurin P
    Hepatology; 2007 Jun; 45(6):1348-54. PubMed ID: 17518367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.
    Park SH; Kim DJ; Kim YS; Yim HJ; Tak WY; Lee HJ; Sohn JH; Yoon KT; Kim IH; Kim HS; Um SH; Baik SK; Lee JS; Suk KT; Kim SG; Suh SJ; Park SY; Kim TY; Jang JY;
    J Hepatol; 2014 Oct; 61(4):792-8. PubMed ID: 24845609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.